The impact of mRNA turnover and translation on age-related muscle loss

Ageing Research Reviews

Volumn 11, Issue 4, 2012, Pages 432-441

  Ma, Jennifer F ^a   Hall, Derek T ^a   Gallouzi, Imed Eddine ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

Ageing; MicroRNA; RNA binding protein; Sarcopenia; Skeletal muscle

Indexed keywords

MESSENGER RNA; MICRORNA; MITOGEN ACTIVATED PROTEIN KINASE P38; MYOD PROTEIN; MYOGENIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN P16; PROTEIN P21; RNA BINDING PROTEIN; TRANSCRIPTION FACTOR PAX7;

AGING; GENE EXPRESSION; GENE EXPRESSION REGULATION; HUMAN; MUSCLE ATROPHY; MUSCLE DEVELOPMENT; MUSCLE MASS; NONHUMAN; PROTEIN ANALYSIS; PROTEIN FUNCTION; REVIEW; RNA ANALYSIS; RNA METABOLISM; RNA TRANSLATION; SKELETAL MUSCLE SATELLITE CELL; TRANSCRIPTION REGULATION;

ANIMALS; HUMANS; MICRORNAS; MUSCLE PROTEINS; MUSCULAR ATROPHY; PROTEIN BIOSYNTHESIS; RNA PROCESSING, POST-TRANSCRIPTIONAL; RNA-BINDING PROTEINS; SARCOPENIA;

EID: 84866514591     PISSN: 15681637     EISSN: 18729649     Source Type: Journal    
DOI: 10.1016/j.arr.2012.05.004     Document Type: Review

References (156)

1. Abdelmohsen K., Kuwano Y., Kim H.H., Gorospe M. Posttranscriptional gene regulation by RNA-binding proteins during oxidative stress: implications for cellular senescence. Biological Chemistry 2008, 389:243-255.
2. Alway S.E., Lowe D.A., Chen K.D. The effects of age and hindlimb supension on the levels of expression of the myogenic regulatory factors MyoD and myogenin in rat fast and slow skeletal muscles. Experimental Physiology 2001, 86:509-517.
3. Anderson P., Kedersha N. Visibly stressed: the role of eIF2, TIA-1, and stress granules in protein translation. Cell Stress and Chaperones 2002, 7:213-221.
4. Anderson R., Prolla T. PGC-1alpha in aging and anti-aging interventions. Biochimica et Biophysica Acta 2009, 1790:1059-1066.
5. Argiles J.M., Busquets S., Felipe A., Lopez-Soriano F.J. Molecular mechanisms involved in muscle wasting in cancer and ageing: cachexia versus sarcopenia. International Journal of Biochemistry and Cell Biology 2005, 37:1084-1104.
6. Baker D.J., Perez-Terzic C., Jin F., Pitel K., Niederlander N.J., Jeganathan K., Yamada S., Reyes S., Rowe L., Hiddinga H.J., Eberhardt N.L., Terzic A., van Deursen J.M. Opposing roles for p16Ink4a and p19Arf in senescence and ageing caused by BubR1 insufficiency. Nature Cell Biology 2008, 10:825-836.
7. Bakheet T., Frevel M., Williams B.R., Greer W., Khabar K.S. ARED: human AU-rich element-containing mRNA database reveals an unexpectedly diverse functional repertoire of encoded proteins. Nucleic Acids Research 2001, 29:246-254.
8. Beckman J.S. Oxidative damage and tyrosine nitration from peroxynitrite. Chemical Research in Toxicology 1996, 9:836-844.
9. Bigot A., Klein A.F., Gasnier E., Jacquemin V., Ravassard P., Butler-Browne G., Mouly V., Furling D. Large CTG repeats trigger p16-dependent premature senescence in myotonic dystrophy type 1 muscle precursor cells. American Journal of Pathology 2009, 174:1435-1442.
10. Blackshear P.J. Tristetraprolin and other CCCH tandem zinc-finger proteins in the regulation of mRNA turnover. Biochemical Society Transactions 2002, 30:945-952.
11. Briata P., Forcales S.V., Ponassi M., Corte G., Chen C.Y., Karin M., Puri P.L., Gherzi R. p38-dependent phosphorylation of the mRNA decay-promoting factor KSRP controls the stability of select myogenic transcripts. Molecular Cell 2005, 20:891-903.
12. Briata P., Lin W.J., Giovarelli M., Pasero M., Chou C.F., Trabucchi M., Rosenfeld M.G., Chen C.Y., Gherzi R. PI3K/AKT signaling determines a dynamic switch between distinct KSRP functions favoring skeletal myogenesis. Cell Death and Differentiation 2012, 19:478-487.
13. Burton L.A., Sumukadas D. Optimal management of sarcopenia. Clinical Interventions in Ageing 2010, 5:217-228.
14. Cai D., Frantz J.D., Tawa N.E., Melendez P.A., Oh B.-C., Lidov H.G.W., Hasselgren P.-O., Frontera W.R., Lee J., Glass D.J., Shoelson S.E. IKKbeta/NF-kappaB Activation Causes Severe Muscle Wasting in Mice. Cell 2004, 119:285-298.
15. Campisi J., Andersen J.K., Kapahi P., Melov S. Cellular senescence: a link between cancer and age-related degenerative disease?. Seminars in Cancer Biology 2011, 21:354-359.
16. Campisi J., d'Adda di Fagagna F. Cellular senescence: when bad things happen to good cells. Nature Reviews Molecular Cell Biology 2007, 8:729-740.
17. Carmell M.A., Xuan Z., Zhang M.Q., Hannon G.J. The Argonaute family: tentacles that reach into RNAi, developmental control, stem cell maintenance, and tumorigenesis. Genes and Development 2002, 16:2733-2742.
18. Cassina A.M., Hodara R., Souza J.M., Thomson L., Castro L., Ischiropoulos H., Freeman B.A., Radi R. Cytochrome c nitration by peroxynitrite. Journal of Biological Chemistry 2000, 275:21409-21415.
19. Chang N., Yi J., Guo G., Liu X., Shang Y., Tong T., Cui Q., Zhan M., Gorospe M., Wang W. HuR uses AUF1 as a cofactor to promote p16INK4 mRNA decay. Molecular and Cellular Biology 2010, 30:3875-3886.
20. Chen C.Y., Gherzi R., Ong S.E., Chan E.L., Raijmakers R., Pruijn G.J., Stoecklin G., Moroni C., Mann M., Karin M. AU binding proteins recruit the exosome to degrade ARE-containing mRNAs. Cell 2001, 107:451-464.
21. Chen C.Y., Shyu A.B. AU-rich elements: characterization and importance in mRNA degradation. Trends in Biochemical Sciences 1995, 20:465-470.
22. Chen J.F., Tao Y., Li J., Deng Z., Yan Z., Xiao X., Wang D.Z. microRNA-1 and microRNA-206 regulate skeletal muscle satellite cell proliferation and differentiation by repressing Pax7. Journal of Cell Biology 2010, 190:867-879.
23. Chen Y.L., Huang Y.L., Lin N.Y., Chen H.C., Chiu W.C., Chang C.J. Differential regulation of ARE-mediated TNFalpha and IL-1beta mRNA stability by lipopolysaccharide in RAW264.7 cells. Biochemical and Biophysical Research Communications 2006, 346:160-168.
24. Collins C.A., Zammit P.S., Ruiz A.P., Morgan J.E., Partridge T.A. A population of myogenic stem cells that survives skeletal muscle aging. Stem Cells 2007, 25:885-894.
25. Conboy I.M., Conboy M.J., Wagers A.J., Girma E.R., Weissman I.L., Rando T.A. Rejuvenation of aged progenitor cells by exposure to a young systemic environment. Nature 2005, 433:760-764.
26. Coppe J.P., Rodier F., Patil C.K., Freund A., Desprez P.Y., Campisi J. Tumor suppressor and aging biomarker p16(INK4a) induces cellular senescence without the associated inflammatory secretory phenotype. Journal of Biological Chemistry 2011, 286:36396-36403.
27. Cruz-Jentoft A.J., Baeyens J.P., Bauer J.M., Boirie Y., Cederholm T., Landi F., Martin F.C., Michel J.P., Rolland Y., Schneider S.M., Topinkova E., Vandewoude M., Zamboni M. Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age and Ageing 2010, 39:412-423.
28. Deleault K.M., Skinner S.J., Brooks S.A. Tristetraprolin regulates TNF TNF-alpha mRNA stability via a proteasome dependent mechanism involving the combined action of the ERK and p38 pathways. Molecular Immunology 2008, 45:13-24.
29. Deschenes M.R. Effects of aging on muscle fibre type and size. Sports Medicine 2004, 34:809-824.
30. Dey B.K., Gagan J., Dutta A. miR-206 and -486 induce myoblast differentiation by downregulating Pax7. Molecular and Cellular Biology 2011, 31:203-214.
31. Di Marco S., Hel Z., Lachance C., Furneaux H., Radzioch D. Polymorphism in the 3'-untranslated region of TNFalpha mRNA impairs binding of the post-transcriptional regulatory protein HuR to TNFalpha mRNA. Nucleic Acids Research 2001, 29:863-871.
32. Di Marco S., Mazroui R., Dallaire P., Chittur S., Tenenbaum S.A., Radzioch D., Marette A., Gallouzi I.E. NF-kappa B-mediated MyoD decay during muscle wasting requires nitric oxide synthase mRNA stabilization, HuR protein, and nitric oxide release. Molecular and Cellular Biology 2005, 25:6533-6545.
33. Drummond M.J., McCarthy J.J., Fry C.S., Esser K.A., Rasmussen B.B. Aging differentially affects human skeletal muscle microRNA expression at rest and after an anabolic stimulus of resistance exercise and essential amino acids. American Journal of Physiology. Endocrinology and Metabolism 2008, 295:E1333-E1340.
34. Drummond M.J., McCarthy J.J., Sinha M., Spratt H.M., Volpi E., Esser K.A., Rasmussen B.B. Aging and microRNA expression in human skeletal muscle: a microarray and bioinformatics analysis. Physiological Genomics 2011, 43:595-603.
35. Eisenberg I., Eran A., Nishino I., Moggio M., Lamperti C., Amato A.A., Lidov H.G., Kang P.B., North K.N., Mitrani-Rosenbaum S., Flanigan K.M., Neely L.A., Whitney D., Beggs A.H., Kohane I.S., Kunkel L.M. Distinctive patterns of microRNA expression in primary muscular disorders. Proceedings of the National Academy of Sciences of the United States of America 2007, 104:17016-17021.
36. Evans W.J. Skeletal muscle loss: cachexia, sarcopenia, and inactivity. American Journal of Clinical Nutrition 2010, 91:1123S-1127S.
37. Evans W.J., Morley J.E., Argiles J., Bales C., Baracos V., Guttridge D., Jatoi A., Kalantar-Zadeh K., Lochs H., Mantovani G., Marks D., Mitch W.E., Muscaritoli M., Najand A., Ponikowski P., Rossi Fanelli F., Schambelan M., Schols A., Schuster M., Thomas D., Wolfe R., Anker S.D. Cachexia: a new definition. Clinical Nutrition 2008, 27:793-799.
38. Fabian M.R., Sonenberg N., Filipowicz W. Regulation of mRNA translation and stability by microRNAs. Annual Review of Biochemistry 2010, 79:351-379.
39. Fardaei M., Rogers M.T., Thorpe H.M., Larkin K., Hamshere M.G., Harper P.S., Brook J.D. Three proteins, MBNL. MBLL and MBXL, co-localize in vivo with nuclear foci of expanded-repeat transcripts in DM1 and DM2 cells. Hum Mol Genet 2002, 11:805-814.
40. Figueiredo P.A., Mota M.P., Appell H.J., Duarte J.A. The role of mitochondria in aging of skeletal muscle. Biogerontology 2008, 9:67-84.
41. Filipowicz W., Bhattacharyya S.N., Sonenberg N. Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight?. Nature Reviews. Genetics 2008, 9:102-114.
42. Franceschi C., Bonafe M., Valensin S., Olivieri F., De Luca M., Ottaviani E., De Benedictis G. Inflamm-aging. An evolutionary perspective on immunosenescence. Annals of the New York Academy of Sciences 2000, 908:244-254.
43. Fulle S., Protasi F., Di Tano G., Pietrangelo T., Beltramin A., Boncompagni S., Vecchiet L., Fano G. The contribution of reactive oxygen species to sarcopenia and muscle ageing. Experimental Gerontology 2004, 39:17-24.
44. Garnham C.P., Hanna R.A., Chou J.S., Low K.E., Gourlay K., Campbell R.L., Beckmann J.S., Davies P.L. Limb-girdle muscular dystrophy type 2A can result from accelerated autoproteolytic inactivation of calpain 3. Biochemistry 2009, 48:3457-3467.
45. Gherzi R., Lee K.Y., Briata P., Wegmuller D., Moroni C., Karin M., Chen C.Y. A KH domain RNA binding protein, KSRP, promotes ARE-directed mRNA turnover by recruiting the degradation machinery. Molecular Cell 2004, 14:571-583.
46. Goljanek-Whysall K., Sweetman D., Abu-Elmagd M., Chapnik E., Dalmay T., Hornstein E., Munsterberg A. MicroRNA regulation of the paired-box transcription factor Pax3 confers robustness to developmental timing of myogenesis. Proceedings of the National Academy of Sciences of the United States of America 2011, 108:11936-11941.
47. Gueydan C., Droogmans L., Chalon P., Huez G., Caput D., Kruys V. Identification of TIAR as a protein binding to the translational regulatory AU-rich element of tumor necrosis factor alpha mRNA. Journal of Biological Chemistry 1999, 274:2322-2326.
48. Guhaniyogi J., Brewer G. Regulation of mRNA stability in mammalian cells. Gene 2001, 265:11-23.
49. Guillet C., Boirie Y. Insulin resistance: a contributing factor to age-related muscle mass loss?. Diabetes & Metabolism 2005, 31(Spec No 2):5S20-25S26.
50. Guo G.E., Ma L.W., Jiang B., Yi J., Tong T.J., Wang W.G. Hydrogen peroxide induces p16INK4a through an AUF1-dependent manner. Journal of Cellular Biochemistry 2010, 109:1000-1005.
51. Hacham M., White R.M., Argov S., Segal S., Apte R.N. Interleukin-6 and interleukin-10 are expressed in organs of normal young and old mice. European Cytokine Network 2004, 15:37-46.
52. Haddad F., Zaldivar F., Cooper D.M., Adams G.R. IL-6-induced skeletal muscle atrophy. Journal of Applied Physiology 2005, 98:911-917.
53. Harris T.B., Ferrucci L., Tracy R.P., Corti M.C., Wacholder S., Ettinger W.H., Heimovitz H., Cohen H.J., Wallace R. Associations of elevated Interleukin-6 and C-reactive protein levels with mortality in the elderly. American Journal of Medicine 1999, 106:506-512.
54. Hawke T.J., Meeson A.P., Jiang N., Graham S., Hutcheson K., DiMaio J.M., Garry D.J. p21 is essential for normal myogenic progenitor cell function in regenerating skeletal muscle. American Journal of Physiology. Cell Physiology 2003, 285:C1019-C1027.
55. Hepple R.T. Dividing to keep muscle together: the role of satellite cells in aging skeletal muscle. Science of Aging Knowledge Environment 2006, 2006:pe3.
56. Hinman M., Lou H. Diverse molecular functions of Hu proteins. Cellular and Molecular Life Sciences 2008, 65:3168-3181.
57. Ho T.H., Bundman D., Armstrong D.L., Cooper T.A. Transgenic mice expressing CUG-BP1 reproduce splicing mis-regulation observed in myotonic dystrophy. Human Molecular Genetics 2005, 14:1539-1547.
58. Hocine S., Singer R.H., Grunwald D. RNA processing and export. Cold Spring Harbor Perspectives in Biology 2010, 2:a000752.
59. Iakova P., Wang G.L., Timchenko L., Michalak M., Pereira-Smith O.M., Smith J.R., Timchenko N.A. Competition of CUGBP1 and calreticulin for the regulation of p21 translation determines cell fate. The EMBO Journal 2004, 23:406-417.
60. Ito Y., Shibata N., Saito K., Kobayashi M., Osawa M. New insights into the pathogenesis of spinal muscular atrophy. Brain and Development 2011, 33:321-331.
61. Janssen I., Shepard D.S., Katzmarzyk P.T., Roubenoff R. The healthcare costs of sarcopenia in the United States. Journal of the American Geriatrics Society 2004, 52:80-85.
62. Jejurikar S.S., Henkelman E.A., Cederna P.S., Marcelo C.L., Urbanchek M.G., Kuzon W.M. Aging increases the susceptibility of skeletal muscle derived satellite cells to apoptosis. Experimental Gerontology 2006, 41:828-836.
63. Jensen G.L. Inflammation: roles in aging and sarcopenia. JPEN. Journal of Parenteral and Enteral Nutrition 2008, 32:656-659.
64. Jing Q., Huang S., Guth S., Zarubin T., Motoyama A., Chen J., Di Padova F., Lin S.C., Gram H., Han J. Involvement of microRNA in AU-rich element-mediated mRNA instability. Cell 2005, 120:623-634.
65. Jones K., Jin B., Iakova P., Huichalaf C., Sarkar P., Schneider-Gold C., Schoser B., Meola G., Shyu A.B., Timchenko N., Timchenko L. RNA foci, CUGBP1, and ZNF9 are the primary targets of the mutant CUG and CCUG repeats expanded in myotonic dystrophies type 1 and type 2. American Journal of Pathology 2011, 179:2475-2489.
66. Kanadia R.N., Johnstone K.A., Mankodi A., Lungu C., Thornton C.A., Esson D., Timmers A.M., Hauswirth W.W., Swanson M.S. A muscleblind knockout model for myotonic dystrophy. Science 2003, 302:1978-1980.
67. Kanski J., Alterman M.A., Schoneich C. Proteomic identification of age-dependent protein nitration in rat skeletal muscle. Free Radical Biology and Medicine 2003, 35:1229-1239.
68. Katsanou V., Milatos S., Yiakouvaki A., Sgantzis N., Kotsoni A., Alexiou M., Harokopos V., Aidinis V., Hemberger M., Kontoyiannis D.L. The RNA-binding protein Elavl1/HuR is essential for placental branching morphogenesis and embryonic development. Molecular and Cellular Biology 2009, 29:2762-2776.
69. Kedersha N.L., Gupta M., Li W., Miller I., Anderson P. RNA-binding proteins TIA-1 and TIAR link the phosphorylation of eIF-2 alpha to the assembly of mammalian stress granules. Journal of Cell Biology 1999, 147:1431-1442.
70. Kim H.K., Lee Y.S., Sivaprasad U., Malhotra A., Dutta A. Muscle-specific microRNA miR-206 promotes muscle differentiation. Journal of Cell Biology 2006, 174:677-687.
71. Kino Y., Mori D., Oma Y., Takeshita Y., Sasagawa N., Ishiura S. Muscleblind protein, MBNL1/EXP, binds specifically to CHHG repeats. Human Molecular Genetics 2004, 13:495-507.
72. Kishore S., Luber S., Zavolan M. Deciphering the role of RNA-binding proteins in the post-transcriptional control of gene expression. Brief Funct Genomics 2010, 9:391-404.
73. Krecic A.M., Swanson M.S. hnRNP complexes: composition, structure, and function. Current Opinion in Cell Biology 1999, 11:363-371.
74. Kress C., Gautier-Courteille C., Osborne H.B., Babinet C., Paillard L. Inactivation of CUG-BP1/CELF1 causes growth, viability, and spermatogenesis defects in mice. Molecular and Cellular Biology 2007, 27:1146-1157.
75. Lai W.S., Kennington E.A., Blackshear P.J. Interactions of CCCH zinc finger proteins with mRNA: non-binding tristetraprolin mutants exert an inhibitory effect on degradation of AU-rich element-containing mRNAs. Journal of Biological Chemistry 2002, 277:9606-9613.
76. Lal A., Kim H.H., Abdelmohsen K., Kuwano Y., Pullmann R., Srikantan S., Subrahmanyam R., Martindale J.L., Yang X., Ahmed F., Navarro F., Dykxhoorn D., Lieberman J., Gorospe M. p16(INK4a) translation suppressed by miR-24. PLoS ONE 2008, 3:e1864.
77. Lal A., Mazan-Mamczarz K., Kawai T., Yang X., Martindale J.L., Gorospe M. Concurrent versus individual binding of HuR and AUF1 to common labile target mRNAs. The EMBO Journal 2004, 23:3092-3102.
78. Landi F., Abbatecola A.M., Provinciali M., Corsonello A., Bustacchini S., Manigrasso L., Cherubini A., Bernabei R., Lattanzio F. Moving against frailty: does physical activity matter?. Biogerontology 2010, 11:537-545.
79. Lang C.H., Frost R.A., Nairn A.C., MacLean D.A., Vary T.C. TNF-alpha impairs heart and skeletal muscle protein synthesis by altering translation initiation. American Journal of Physiology. Endocrinology and Metabolism 2002, 282:E336-E347.
80. Lawler J.M. Exacerbation of pathology by oxidative stress in respiratory and locomotor muscles with Duchenne muscular dystrophy. The Journal of Physiology 2011, 589:2161-2170.
81. Le Grand F., Rudnicki M.A. Skeletal muscle satellite cells and adult myogenesis. Current Opinion in Cell Biology 2007, 19:628-633.
82. Lee J.E., Lee J.Y., Wilusz J., Tian B., Wilusz C.J. Systematic analysis of cis-elements in unstable mRNAs demonstrates that CUGBP1 is a key regulator of mRNA decay in muscle cells. PLoS ONE 2010, 5:e11201.
83. Lenk K., Schuler G., Adams V. Skeletal muscle wasting in cachexia and sarcopenia: molecular pathophysiology and impact of exercise training. Journal of Cachexia, Sarcopenia and Muscle 2010, 1:9-21.
84. Leung A.K., Calabrese J.M., Sharp P.A. Quantitative analysis of Argonaute protein reveals microRNA-dependent localization to stress granules. Proceedings of the National Academy of Sciences of the United States of America 2006, 103:18125-18130.
85. Li Y.P., Chen Y., John J., Moylan J., Jin B., Mann D.L., Reid M.B. TNF-alpha acts via p38 MAPK to stimulate expression of the ubiquitin ligase atrogin1/MAFbx in skeletal muscle. FASEB Journal 2005, 19:362-370.
86. Liao B., Hu Y., Brewer G. Competitive binding of AUF1 and TIAR to MYC mRNA controls its translation. Nature Structural & Molecular Biology 2007, 14:511-518.
87. Lim L.P., Lau N.C., Garrett-Engele P., Grimson A., Schelter J.M., Castle J., Bartel D.P., Linsley P.S., Johnson J.M. Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature 2005, 433:769-773.
88. Lin W.J., Zheng X., Lin C.C., Tsao J., Zhu X., Cody J.J., Coleman J.M., Gherzi R., Luo M., Townes T.M., Parker J.N., Chen C.Y. Posttranscriptional control of type I interferon genes by KSRP in the innate immune response against viral infection. Molecular and Cellular Biology 2011, 31:3196-3207.
89. Liu J., Carmell M.A., Rivas F.V., Marsden C.G., Thomson J.M., Song J.J., Hammond S.M., Joshua-Tor L., Hannon G.J. Argonaute2 is the catalytic engine of mammalian RNAi. Science 2004, 305:1437-1441.
90. Lu J.Y., Sadri N., Schneider R.J. Endotoxic shock in AUF1 knockout mice mediated by failure to degrade proinflammatory cytokine mRNAs. Genes and Development 2006, 20:3174-3184.
91. Mahtani K.R., Brook M., Dean J.L., Sully G., Saklatvala J., Clark A.R. Mitogen-activated protein kinase p38 controls the expression and posttranslational modification of tristetraprolin, a regulator of tumor necrosis factor alpha mRNA stability. Molecular and Cellular Biology 2001, 21:6461-6469.
92. Malatesta M., Perdoni F., Muller S., Pellicciari C., Zancanaro C. Pre-mRNA processing is partially impaired in satellite cell nuclei from aged muscles. Journal of Biomedicine and Biotechnology 2010, 2010:410405.
93. Malatesta M., Perdoni F., Muller S., Zancanaro C., Pellicciari C. Nuclei of aged myofibres undergo structural and functional changes suggesting impairment in RNA processing. European Journal of Histochemistry 2009, 53:97-106.
94. Malhotra S.B., Hart K.A., Klamut H.J., Thomas N.S., Bodrug S.E., Burghes A.H., Bobrow M., Harper P.S., Thompson M.W., Ray P.N., et al. Frame-shift deletions in patients with Duchenne and Becker muscular dystrophy. Science 1988, 242:755-759.
95. Mankodi A., Urbinati C.R., Yuan Q.P., Moxley R.T., Sansone V., Krym M., Henderson D., Schalling M., Swanson M.S., Thornton C.A. Muscleblind localizes to nuclear foci of aberrant RNA in myotonic dystrophy types 1 and 2. Human Molecular Genetics 2001, 10:2165-2170.
96. Masuda K., Marasa B., Martindale J.L., Halushka M.K., Gorospe M. Tissue- and age-dependent expression of RNA-binding proteins that influence mRNA turnover and translation. Aging (Albany NY) 2009, 1:681-698.
97. Mata J., Marguerat S., Bahler J. Post-transcriptional control of gene expression: a genome-wide perspective. Trends in Biochemical Sciences 2005, 30:506-514.
98. Matsumoto K., Minami M., Shinozaki F., Suzuki Y., Abe K., Zenno S., Matsumoto S., Minami Y. Hsp90 is involved in the formation of P-bodies and stress granules. Biochemical and Biophysical Research Communications 2011, 407:720-724.
99. McCarthy J.J. The MyomiR network in skeletal muscle plasticity. Exercise and Sport Sciences Reviews 2011, 39:150-154.
100. Mercuri E., Bushby K., Ricci E., Birchall D., Pane M., Kinali M., Allsop J., Nigro V., Sáenz A., Nascimbeni A., Fulizio L., Angelini C., Muntoni F. Muscle MRI findings in patients with limb girdle muscular dystrophy with calpain 3 deficiency (LGMD2A) and early contractures. Neuromuscular Disorders 2005, 15:164-171.
101. Meshorer E., Soreq H. Pre-mRNA splicing modulations in senescence. Aging Cell 2002, 1:10-16.
102. Miller J.W., Urbinati C.R., Teng-Umnuay P., Stenberg M.G., Byrne B.J., Thornton C.A., Swanson M.S. Recruitment of human muscleblind proteins to (CUG)(n) expansions associated with myotonic dystrophy. The EMBO Journal 2000, 19:4439-4448.
103. Moraes K.C., Wilusz C.J., Wilusz J. CUG-BP binds to RNA substrates and recruits PARN deadenylase. RNA 2006, 12:1084-1091.
104. Moylan J.S., Reid M.B. Oxidative stress, chronic disease, and muscle wasting. Muscle & Nerve 2007, 35:411-429.
105. Narici M.V., Maffulli N. Sarcopenia: characteristics, mechanisms and functional significance. British Medical Bulletin 2010, 95:139-159.
106. Noren Hooten N., Abdelmohsen K., Gorospe M., Ejiogu N., Zonderman A.B., Evans M.K. microRNA expression patterns reveal differential expression of target genes with age. PLoS ONE 2010, 5:e10724.
107. Okano H.J., Darnell R.B. A hierarchy of Hu RNA binding proteins in developing and adult neurons. Journal of Neuroscience 1997, 17:3024-3037.
108. Pare J.M., Lopez-Orozco J., Hobman T.C. MicroRNA-binding is required for recruitment of human Argonaute 2 to stress granules and P-bodies. Biochemical and Biophysical Research Communications 2011, 414:259-264.
109. Park S.K., Prolla T.A. Gene expression profiling studies of aging in cardiac and skeletal muscles. Cardiovascular Research 2005, 66:205-212.
110. Paschoud S., Dogar A.M., Kuntz C., Grisoni-Neupert B., Richman L., Kuhn L.C. Destabilization of interleukin-6 mRNA requires a putative RNA stem-loop structure, an AU-rich element, and the RNA-binding protein AUF1. Molecular and Cellular Biology 2006, 26:8228-8241.
111. Pedersen B.K. Muscles and their myokines. Journal of Experimental Biology 2011, 214:337-346.
112. Phillips K., Kedersha N., Shen L., Blackshear P.J., Anderson P. Arthritis suppressor genes TIA-1 and TTP dampen the expression of tumor necrosis factor alpha, cyclooxygenase 2, and inflammatory arthritis. Proceedings of the National Academy of Sciences of the United States of America 2004, 101:2011-2016.
113. Piecyk M., Wax S., Beck A.R., Kedersha N., Gupta M., Maritim B., Chen S., Gueydan C., Kruys V., Streuli M., Anderson P. TIA-1 is a translational silencer that selectively regulates the expression of TNF-alpha. The EMBO Journal 2000, 19:4154-4163.
114. Qi M.Y., Wang Z.Z., Zhang Z., Shao Q., Zeng A., Li X.Q., Li W.Q., Wang C., Tian F.J., Li Q., Zou J., Qin Y.W., Brewer G., Huang S., Jing Q. AU-rich-element-dependent translation repression requires the cooperation of tristetraprolin and RCK/P54. Molecular and Cellular Biology 2012, 32:913-928.
115. Quinn L.S., Haugk K.L., Grabstein K.H. Interleukin-15: a novel anabolic cytokine for skeletal muscle. Endocrinology 1995, 136:3669-3672.
116. Raineri I., Wegmueller D., Gross B., Certa U., Moroni C. Roles of AUF1 isoforms, HuR and BRF1 in ARE-dependent mRNA turnover studied by RNA interference. Nucleic Acids Research 2004, 32:1279-1288.
117. Rasmussen B.B., Fujita S., Wolfe R.R., Mittendorfer B., Roy M., Rowe V.L., Volpi E. Insulin resistance of muscle protein metabolism in aging. FASEB Journal 2006, 20:768-769.
118. Rowlett R.M., Chrestensen C.A., Schroeder M.J., Harp M.G., Pelo J.W., Shabanowitz J., DeRose R., Hunt D.F., Sturgill T.W., Worthington M.T. Inhibition of tristetraprolin deadenylation by poly(A) binding protein. American Journal of Physiology. Gastrointestinal and Liver Physiology 2008, 295:G421-G430.
119. Saito K., Chen S., Piecyk M., Anderson P. TIA-1 regulates the production of tumor necrosis factor alpha in macrophages, but not in lymphocytes. Arthritis and Rheumatism 2001, 44:2879-2887.
120. Sandri M., Lin J., Handschin C., Yang W., Arany Z.P., Lecker S.H., Goldberg A.L., Spiegelman B.M. PGC-1alpha protects skeletal muscle from atrophy by suppressing FoxO3 action and atrophy-specific gene transcription. Proceedings of the National Academy of Sciences of the United States of America 2006, 103:16260-16265.
121. Schaap L.A., Pluijm S.M., Deeg D.J., Harris T.B., Kritchevsky S.B., Newman A.B., Colbert L.H., Pahor M., Rubin S.M., Tylavsky F.A., Visser M. Higher inflammatory marker levels in older persons: associations with 5-year change in muscle mass and muscle strength. Journals of Gerontology. Series A, Biological Sciences and Medical Sciences 2009, 64:1183-1189.
122. Sehl M.E., Yates F.E. Kinetics of human aging: I. Rates of senescence between ages 30 and 70 years in healthy people. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences 2001, 56:B198-B208.
123. Shefer G., Rauner G., Yablonka-Reuveni Z., Benayahu D. Reduced satellite cell numbers and myogenic capacity in aging can be alleviated by endurance exercise. PLoS ONE 2010, 5:e13307.
124. Singh T., Newman A.B. Inflammatory markers in population studies of aging. Ageing Research Reviews 2011, 10:319-329.
125. Small E.M., O'Rourke J.R., Moresi V., Sutherland L.B., McAnally J., Gerard R.D., Richardson J.A., Olson E.N. Regulation of PI3-kinase/Akt signaling by muscle-enriched microRNA-486. Proceedings of the National Academy of Sciences of the United States of America 2010, 107:4218-4223.
126. Sobczak K., de Mezer M., Michlewski G., Krol J., Krzyzosiak W.J. RNA structure of trinucleotide repeats associated with human neurological diseases. Nucleic Acids Research 2003, 31:5469-5482.
127. Srinivas-Shankar U., Wu F.C. Frailty and muscle function: role for testosterone?. Frontiers of Hormone Research 2009, 37:133-149.
128. Sugiura R., Satoh R., Ishiwata S., Umeda N., Kita A. Role of RNA-binding proteins in MAPK signal transduction pathway. Journal of Signal Transduction 2011, 2011:109746.
129. Sun Q., Zhang Y., Yang G., Chen X., Cao G., Wang J., Sun Y., Zhang P., Fan M., Shao N., Yang X. Transforming growth factor-beta-regulated miR-24 promotes skeletal muscle differentiation. Nucleic Acids Research 2008, 36:2690-2699.
130. Taylor G.A., Carballo E., Lee D.M., Lai W.S., Thompson M.J., Patel D.D., Schenkman D.I., Gilkeson G.S., Broxmeyer H.E., Haynes B.F., Blackshear P.J. A pathogenetic role for TNF alpha in the syndrome of cachexia, arthritis, and autoimmunity resulting from tristetraprolin (TTP) deficiency. Immunity 1996, 4:445-454.
131. Thomas D.R. Loss of skeletal muscle mass in aging: examining the relationship of starvation, sarcopenia and cachexia. Clinical Nutrition 2007, 26:389-399.
132. Timchenko N.A., Cai Z.J., Welm A.L., Reddy S., Ashizawa T., Timchenko L.T. RNA CUG repeats sequester CUGBP1 and alter protein levels and activity of CUGBP1. Journal of Biological Chemistry 2001, 276:7820-7826.
133. Timchenko N.A., Iakova P., Cai Z.J., Smith J.R., Timchenko L.T. Molecular basis for impaired muscle differentiation in myotonic dystrophy. Molecular and Cellular Biology 2001, 21:6927-6938.
134. Timchenko N.A., Patel R., Iakova P., Cai Z.J., Quan L., Timchenko L.T. Overexpression of CUG triplet repeat-binding protein, CUGBP1, in mice inhibits myogenesis. The Journal of Biological Chemistry 2004, 279:13129-13139.
135. Tisdale M.J. Cachexia in cancer patients. Nature Reviews Cancer 2002, 2:862-871.
136. Tisdale M.J. Mechanisms of cancer cachexia. Physiological Reviews 2009, 89:381-410.
137. van der Giessen K., Di-Marco S., Clair E., Gallouzi I.E. RNAi-mediated HuR depletion leads to the inhibition of muscle cell differentiation. Journal of Biological Chemistry 2003, 278:47119-47128.
138. van Deutekom J.C., Wijmenga C., van Tienhoven E.A., Gruter A.M., Hewitt J.E., Padberg G.W., van Ommen G.J., Hofker M.H., Frants R.R. FSHD associated DNA rearrangements are due to deletions of integral copies of a 3.2kb tandemly repeated unit. Human Molecular Genetics 1993, 2:2037-2042.
139. van Rooij E., Quiat D., Johnson B.A., Sutherland L.B., Qi X., Richardson J.A., Kelm R.J., Olson E.N. A family of microRNAs encoded by myosin genes governs myosin expression and muscle performance. Developmental Cell 2009, 17:662-673.
140. van Rooij E., Sutherland L.B., Qi X., Richardson J.A., Hill J., Olson E.N. Control of stress-dependent cardiac growth and gene expression by a microRNA. Science 2007, 316:575-579.
141. Vasudevan S., Tong Y., Steitz J.A. Switching from repression to activation: microRNAs can up-regulate translation. Science 2007, 318:1931-1934.
142. Visser M., Pahor M., Taaffe D.R., Goodpaster B.H., Simonsick E.M., Newman A.B., Nevitt M., Harris T.B. Relationship of interleukin-6 and tumor necrosis factor-alpha with muscle mass and muscle strength in elderly men and women: the Health ABC Study. Journals of Gerontology. Series A, Biological Sciences and Medical Sciences 2002, 57:M326-M332.
143. Vlasova I.A., Tahoe N.M., Fan D., Larsson O., Rattenbacher B., Sternjohn J.R., Vasdewani J., Karypis G., Reilly C.S., Bitterman P.B., Bohjanen P.R. Conserved GU-rich elements mediate mRNA decay by binding to CUG-binding protein 1. Molecular Cell 2008, 29:263-270.
144. Vlasova-St Louis I., Bohjanen P.R. Coordinate regulation of mRNA decay networks by GU-rich elements and CELF1. Current Opinion in Genetics and Development 2011, 21:444-451.
145. von Roretz C., Beauchamp P., Di Marco S., Gallouzi I.E. HuR and myogenesis: being in the right place at the right time. Biochimica et Biophysica Acta 2011, 1813:1663-1667.
146. von Roretz C., Di Marco S., Mazroui R., Gallouzi I.E. Turnover of AU-rich-containing mRNAs during stress: a matter of survival. Wiley Interdisciplinary Reviews: RNA 2011, 2:336-347.
147. von Roretz C., Gallouzi I.E. Decoding ARE-mediated decay: is microRNA part of the equation?. Journal of Cell Biology 2008, 181:189-194.
148. Wang W., Martindale J.L., Yang X., Chrest F.J., Gorospe M. Increased stability of the p16 mRNA with replicative senescence. EMBO Reports 2005, 6:158-164.
149. Waters D.L., Baumgartner R.N. Sarcopenia and obesity. Clinics in Geriatric Medicine 2011, 27:401-421.
150. Welle S., Brooks A.I., Delehanty J.M., Needler N., Bhatt K., Shah B., Thornton C.A. Skeletal muscle gene expression profiles in 20-29 year old and 65-71 year old women. Experimental Gerontology 2004, 39:369-377.
151. Welle S., Brooks A.I., Delehanty J.M., Needler N., Thornton C.A. Gene expression profile of aging in human muscle. Physiological Genomics 2003, 14:149-159.
152. Wenz T., Rossi S.G., Rotundo R.L., Spiegelman B.M., Moraes C.T. Increased muscle PGC-1alpha expression protects from sarcopenia and metabolic disease during aging. Proceedings of the National Academy of Sciences of the United States of America 2009, 106:20405-20410.
153. Wojciechowska M., Krzyzosiak W.J. Cellular toxicity of expanded RNA repeats: focus on RNA foci. Human Molecular Genetics 2011, 20:3811-3821.
154. Young L.E., Moore A.E., Sokol L., Meisner-Kober N., Dixon D.A. The mRNA stability factor HuR inhibits microRNA-16 targeting of COX-2. Molecular Cancer Research 2012, 10:167-180.
155. Zhang L., Lee J.E., Wilusz J., Wilusz C.J. The RNA-binding protein CUGBP1 regulates stability of tumor necrosis factor mRNA in muscle cells: implications for myotonic dystrophy. Journal of Biological Chemistry 2008, 283:22457-22463.
156. Zhao W., Liu M., D'Silva N.J., Kirkwood K.L. Tristetraprolin regulates interleukin-6 expression through p38 MAPK-dependent affinity changes with mRNA 3' untranslated region. Journal of Interferon and Cytokine Research 2011, 31:629-637.